These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3509959

  • 1. The effect of amino acid derivative of clofibric acid (WKLB-5), and theophylline monoester of nicotinic acid (ME1) on the development of experimental atherosclerosis in rabbits.
    Wójcicki J, Jaworska M, Samochowiec L, Hinek A.
    Pol J Pharmacol Pharm; 1986; 38(1):77-84. PubMed ID: 3509959
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypolipemic profile of plafibride in a model of experimental atherosclerosis.
    Badimón JJ, Padró T, Cánovas M, Vidal M, Villaverde CA.
    Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):613-7. PubMed ID: 6668971
    [Abstract] [Full Text] [Related]

  • 6. Extractum Fagopyri reduces atherosclerosis in high-fat diet fed rabbits.
    Wójcicki J, Barcew-Wiszniewska B, Samochowiec L, Rózewicka L.
    Pharmazie; 1995 Aug; 50(8):560-2. PubMed ID: 7568319
    [Abstract] [Full Text] [Related]

  • 7. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
    Filip M, Păduraru I, Hriscu A, Neacşu R, Dănilă G, Filip F.
    Rev Med Chir Soc Med Nat Iasi; 1987 Aug; 91(2):341-5. PubMed ID: 3685700
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative studies on the influence of Provasan, Complamine, Sadamine, A-100 and Clofibrat on the behaviour of some lipid fractions of plasma in experimental animals.
    Sulowska Z.
    Mater Med Pol; 1974 Aug; 6(2):102-6. PubMed ID: 4431240
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental studies on the effect of caffeine on the development of atherosclerosis in rabbits.
    Kedra M, Poleszak J, Chibowski D, Cholewa J.
    Pol Med J; 1970 Aug; 9(5):1045-52. PubMed ID: 5510272
    [No Abstract] [Full Text] [Related]

  • 12. Endocrine functions in atherosclerotic rabbits.
    Wójcicki J, Tustanowski S, Samochowiec L.
    Pol J Pharmacol Pharm; 1989 Aug; 41(2):109-13. PubMed ID: 2594577
    [Abstract] [Full Text] [Related]

  • 13. Effect of etofibrate and its metabolites on atheromas of rabbits and on smooth muscle cell cultures.
    Betz E, Hämmerle H.
    Arzneimittelforschung; 1986 Aug; 36(1):92-8. PubMed ID: 3954822
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the effects of plafibride and lysine acetyl salicylate on the production of PGI2].
    Lasierra J, Díez MM, Fernández A, Viladés E, Gil M, Velázquez E.
    Sangre (Barc); 1983 Aug; 28(6):687-95. PubMed ID: 6424250
    [No Abstract] [Full Text] [Related]

  • 15. Effect of clofibrate on aortic glycosamine-glycans and proteins and on serum lipid levels in experimental atherosclerosis.
    Bihari-Varga M, Fehér J, Varsányi M, Gerö S.
    Acta Med Acad Sci Hung; 1973 Aug; 29(3):217-29. PubMed ID: 4270563
    [No Abstract] [Full Text] [Related]

  • 16. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B, Gasparini Casari M, DiBlasio P, Zirilli E.
    Arzneimittelforschung; 1981 Aug; 31(10a):1863-6. PubMed ID: 7032534
    [Abstract] [Full Text] [Related]

  • 17. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE, Perrea DN, Yatzidis HA.
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU, Granzer E.
    Artery; 1980 Jun; 8(5):475-81. PubMed ID: 7011266
    [Abstract] [Full Text] [Related]

  • 19. [Atherosclerosis treatment with etofibrate retard. New perspectives].
    Degenring FH, Schatton W, Hotz W.
    Fortschr Med; 1983 Aug 11; 101(30):1391-6. PubMed ID: 6618402
    [Abstract] [Full Text] [Related]

  • 20. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E, Egge H, Cuttin S, Murawski U, Gibelli A, Giarola P.
    Farmaco Sci; 1973 Sep 11; 28(9):713-21. PubMed ID: 4749857
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.